A new @Nature feature on autism with real data and facts
Published today, written before the Tylenol debacle.
' Kennedy and the HHS are “going to falsely
declare the cause for autism — and that that
gets in the way of a great deal of progress”.'
https://t.co/p1JSMAj1Z5
Huntington's disease was successfully treated for the first time with gene therapy.
75% reduction in symptoms & 113% protection of cognition.
This is what a real medical breakthrough looks like.
Operation Sindoor: It is India's arguably The most successful Military and Diplomatic operation till date.
India is decisively victorious in true sense at both front.
Many argue:
India could have taken POK.
India could have freed Baloch, may be KFP too.
But India accepted Pakistan's request of ceasefire.
Leading oppn party is doing a comparision forgetting India lost 100,000+ SqKM under their rule.
I am telling this most successful operation because of past blunders.
Do you know India's diplomatic blunder since Independence:
Read this thread till the end:
The branded version of semaglutide, called #Ozempic, has surged in popularity—and notoriety—for its off-label use as a weight-loss medication. Here’s what to know about this in-demand drug. https://t.co/CN3yCtdwTy
It's an incredible day for structure-based vaccine design, and I'm thrilled to see our prefusion RSV F antigen get approved as the first RSV vaccine. Still more work to do to reduce the RSV disease burden, but this will help! Congrats @BarneyGrahamMD! https://t.co/8L5JaNy49o
In a phase 3 trial, adults (≥60 years of age) received one 120-μg dose of RSVpreF vaccine or placebo. Vaccine efficacy against RSV-associated lower respiratory tract illness was 67 to 86%. https://t.co/R9u77iWjF9
Imagine human history were written in a big 1,000-page book. Every page would cover 250 years. If we tore out all the pages, it would look like this.
The very earliest permanent settlements started around page 760 and recorded history doesn't start until around page 775.
1/5
A small thread on:
1) Why we are alerted but not too concerned of the global effects of the massive wave of COVID-19 in China,
2) Why the proposed restrictions from Italy & USA are not likely to be effective.
3) Some simple global interventions for 2023.
Happy to share with you our review on ALCOHOL-ASSOCIATED HEPATITIS, published today in the @NEJM.
We dedicate it to all our patients. We will continue to work together to beat it.
@Dr_Vijay_Shah@juanpabloarab
https://t.co/Sq4QX806Pq #LiverTwitter#MedTwitter
So many calls about China, about what that means for India, about XBB, about 3rd waves, about new mandates, about travel bans, about vaccine boosters- thought best to get views out to summarise the current situation. Long thread, be warned 🙂 1/n
We've never had medications that can safely achieve ≥20% body weight loss. With over 1 billion people with obesity and >40% of American adults, the implications (both good and bad) are profound
https://t.co/SMZO20ExDk
A brief update on global SARS-CoV-2 variants:
* BQ.1.1 spreads, albeit at the low end of expectations
* XBB* and BQ* lineages are the most widespread
* Further new variants have been defined, including CK.2.1.1 leading to complex patterns
Epstein-Barr virus is the leading cause of multiple sclerosis
https://t.co/Q7aEwL45Zw
Summary of one of the most important advances in life science this year @ScienceMagazine
https://t.co/2tUgZrfxye
Received an email from Rino Rappuoli this morning informing me, @BarneyGrahamMD and Peter Kwong of the positive phase III data for the RSV prefusion F vaccine results in older adults. It's been almost 10 years since we designed the first prefusion RSV F antigen, DS-Cav1. Amazing!